Seeking Alpha

Endo Pharmaceuticals Holdings Inc. (ENDP)

()

News & PR
Market Currents

Buzz
Twitter: ENDP

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

This Week's Failed Trials, Missed Targets in Biotech

Dec 20, 2009 • The Burrill Report • 1 Comment
Endo Pharma Gets a Setback

Dec 11, 2009 • Zacks.com • 1 Comment
December's Game Plan for Biotech

Dec 1, 2009 • Justin M. Hall • 4 Comments
12 Cheap Growth Companies

Oct 25, 2009 • Hao Jin • 24 Comments
11 Ache-Free Investment Opportunities in Neuropathic Pain

Sep 30, 2009 • Michael Becker • 1 Comment
Six Additions to My Greenblatt-Style 'Magic Formula' List

Sep 21, 2009 • The Manual of Ideas • 1 Comment
Five Drug Makers with Pending Catalysts

Sep 1, 2009 • Justin M. Hall • 46 Comments
Three Recent Biotech Activist Wins by Carl Icahn

Aug 31, 2009 • Michael Becker • 4 Comments
Several Promising Deals for Biotech

Aug 30, 2009 • The Burrill Report • 1 Comment
Top Ranked Magic Formula Stocks in Motley Fool CAPS

Aug 24, 2009 • MagicDiligence • 1 Comment
Thursday Options Update: ENDP, ABC, GE, & DOW

Jul 30, 2009 • Andrew Wilkinson • Comment!
Wall Street Breakfast: Must-Know News

Jul 30, 2009 • SA Editor Rachael Granby • 16 Comments
Scratching My Data Itch: Analysts at Earnings Calls

Jul 30, 2009 • Deviant Alpha • 2 Comments
FDA Calendar: 2H09 Binary Event Trades

Jul 27, 2009 • Mike Havrilla • 3 Comments
Generic Players Continue to Impress in H1

Jul 2, 2009 • EP Vantage • Comment!
Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines

Jun 30, 2009 • ThreeBrothersHealth.com • 4 Comments
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch

Jun 28, 2009 • Marco Hickey • 1 Comment
Endo Pharmaceuticals Should Thrive as Boomers Age

Jun 24, 2009 • Mark Riddix • Comment!
Buys for a Down Day

Jun 23, 2009 • Mark Riddix • 3 Comments
Seven Laggard Biotech Trades

Jun 18, 2009 • Mike Havrilla • Comment!
Wall Street Breakfast: Must-Know News

Apr 29, 2009 • SA Editor Rachael Granby • 30 Comments
Does More Cash and Less Debt Equal Stock Market Gains?

Apr 23, 2009 • Trade Radar Operator • 1 Comment
A Look at D.E. Shaw's Q408 Holdings: Just for Fun

Apr 22, 2009 • Market Folly • 2 Comments
Successfully Investing in Biotech: Smaller Companies, Lots of Patience

Apr 1, 2009 • Ron Sommer • Comment!
Endo Pharmaceuticals' Growth Story

Mar 23, 2009 • Ron Sommer • 1 Comment
FDA and Clinical Trial Updates: United Therapeutics Faces Delays

Mar 18, 2009 • Mike Havrilla • 1 Comment
Forest Laboratories: Perhaps the Next Consolidator?

Jan 27, 2009 • Prudent Speculations • 3 Comments
What to Buy and Why: Barron's 2009 Roundtable, Part III

Jan 25, 2009 • SA Editor Eli Hoffmann • 19 Comments
Hedge Fund Portfolio Tracking: D.E. Shaw & Co (David E. Shaw), Q3 2008

Jan 16, 2009 • Market Folly • 1 Comment
2009: Positive Outlook for Biotech

Jan 8, 2009 • Michael Becker • 1 Comment
Indevus / Endo Pharmaceuticals Merger Looks Good to Go

Jan 7, 2009 • The M & A Researcher • 1 Comment
What Will Brown Do for Merck?

Jan 7, 2009 • Mike Huckman • Comment!
Pfizer Should Buy Amgen or Wyeth - Credit Suisse

Mar 9, 2008 • Mike Huckman • 1 Comment
Zingo Approval Makes Anesiva An Appealing Takeover Target for Endo Pharma

Aug 20, 2007 • Mike Havrilla • Comment!
Barron's Mid-2007 Analyst Roundtable

Jun 17, 2007 • Bill Gross • 3 Comments
Biotech In Review: Adams Respiratory Guides Lower

Mar 18, 2007 • Centient Biotech Investor • Comment!
Investing in Small Cap Pharmaceuticals: Noven, Barrier, Penwest and Endo

Jan 8, 2007 • The Wall Street Transcript • Comment!
Anika Therapeutics Outshines its Peers

Aug 22, 2006 • Erik Dellith • Comment!

Endo Pharmaceuticals Holdings Inc. (ENDP)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers